ArticleAmerican journal of nephrology2021

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.

Glenn M Chertow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.